| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 138, Issue 4 1190-1195, Copyright © 1987 by American Association of Immunologists
ARTICLES |
L Baud, J Perez, M Denis and R Ardaillou
Because infiltration of mononuclear cells and fibroblast proliferation are associated in chronic inflammatory lesions, we tested the hypothesis that leukotrienes (LT), a product of activated mononuclear cells, may modulate fibroblast growth. Proliferation of cultured human skin fibroblasts was estimated by [3H]thymidine incorporation and cell count at increasing concentrations (0.1 nM to 0.1 microM) of LTC4 or LTD4. LTC4 and LTD4 stimulated cell growth in a dose-dependent manner only in the presence of 50 microM indomethacin. Under similar conditions, LTE4 but not LTB4 (0.1 microM) was active. Both asynchronous, growing cells and synchronous, quiescent cells were sensitive to LT when prostaglandin (PG) synthesis was suppressed by indomethacin. Other blockers of cyclooxygenase such as ibuprofen and aspirin exhibited identical permissive activity, and the effect of indomethacin was totally abolished by addition of PGE2. LTC4 modified neither [3H]arachidonic acid release from prelabeled fibroblasts nor PGE2 production by fibroblasts. These results demonstrate that the sulfidopeptide LT stimulate fibroblast proliferation only when the endogenous synthesis of PG is blocked, but they do not enhance the synthesis of PG in their target cells showing no evidence for a negative feed-back loop. Nevertheless, it seems likely that the initiation and development of the fibrotic process in the different tissues depends in part on the local balance between PG and LT productions.
This article has been cited by other articles:
|
|
 |
|
  K. M. Vannella, T. R. McMillan, R. P. Charbeneau, C. A. Wilke, P. E. Thomas, G. B. Toews, M. Peters-Golden, and B. B. Moore Cysteinyl Leukotrienes Are Autocrine and Paracrine Regulators of Fibrocyte Function J. Immunol., December 1, 2007; 179(11): 7883 - 7890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-W. Perng, Y.-C. Wu, K.-T. Chang, M.-T. Wu, Y.-C. Chiou, K.-C. Su, R.-P. Perng, and Y.-C. Lee Leukotriene C4 Induces TGF-{beta}1 Production in Airway Epithelium via p38 Kinase Pathway Am. J. Respir. Cell Mol. Biol., January 1, 2006; 34(1): 101 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Busse and M. Kraft Cysteinyl Leukotrienes in Allergic Inflammation: Strategic Target for Therapy Chest, April 1, 2005; 127(4): 1312 - 1326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Beller, A. Maekawa, D. S. Friend, K. F. Austen, and Y. Kanaoka Targeted Gene Disruption Reveals the Role of the Cysteinyl Leukotriene 2 Receptor in Increased Vascular Permeability and in Bleomycin-induced Pulmonary Fibrosis in Mice J. Biol. Chem., October 29, 2004; 279(44): 46129 - 46134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Beller, D. S. Friend, A. Maekawa, B. K. Lam, K. F. Austen, and Y. Kanaoka Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis PNAS, March 2, 2004; 101(9): 3047 - 3052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Li, G. Yang, M. Khan, D. Stone, S. L-Y. Woo, and J. H-C. Wang Inflammatory Response of Human Tendon Fibroblasts to Cyclic Mechanical Stretching Am. J. Sports Med., March 1, 2004; 32(2): 435 - 440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Zeldin The 5-Lipoxygenase Pathway . A New Therapeutic Target for the Treatment of Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 146 - 147. [Full Text] [PDF]
|
|
|
|
|
|
M. PETERS-GOLDEN, M. BAILIE, T. MARSHALL, C. WILKE, S. H. PHAN, G. B. TOEWS, and B. B. MOORE Protection from Pulmonary Fibrosis in Leukotriene-Deficient Mice Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 229 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Keerthisingam, R. G. Jenkins, N. K. Harrison, N. A. Hernandez-Rodriguez, H. Booth, G. J. Laurent, S. L. Hart, M. L. Foster, and R. J. McAnulty Cyclooxygenase-2 Deficiency Results in a Loss of the Anti-Proliferative Response to Transforming Growth Factor-{beta} in Human Fibrotic Lung Fibroblasts and Promotes Bleomycin-Induced Pulmonary Fibrosis in Mice Am. J. Pathol., April 1, 2001; 158(4): 1411 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. E. Steele, C. A. Holmes, E. T. Hawk, L. Kopelovich, R. A. Lubet, J. A. Crowell, C. C. Sigman, and G. J. Kelloff Lipoxygenase Inhibitors as Potential Cancer Chemopreventives Cancer Epidemiol. Biomarkers Prev., May 1, 1999; 8(5): 467 - 483. [Abstract] [Full Text]
|
|
|
|
 |
|
 V. Patella, I. Marino, E. Arbustini, B. Lamparter-Schummert, L. Verga, M. Adt, and G. Marone Stem Cell Factor in Mast Cells and Increased Mast Cell Density in Idiopathic and Ischemic Cardiomyopathy Circulation, March 17, 1998; 97(10): 971 - 978. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
